Regulation & Policy
Corporate report: MHRA Strategy 2030
How the MHRA Strategy to 2030 sets out to deliver health and prosperity for all, through scientific excellence.
Archive
All articles
2772 published stories · page 5 of 185. Editor summaries with links to original reporting — see Editorial analysis for original commentary, or Latest on the hub.
Market & Brands
Independent retailers raise £10bn for Lottery Good Causes
More than 680,000 projects have received National Lottery funding since its launch in 1994
Market & Brands
Aldi and Lidl dish out Thanksgiving meal deals for under $40
While both bundles can feed 10 people and include sides and dessert fixings, the discounters are taking different approaches to serving up value to their shoppers.
Market & Brands
Medicines: apply for a variation to your marketing authorisation
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Regulation & Policy
Research: Wastewater analysis: estimating drug consumption, 2021 to 2026
Updated 2021 to 2026 trends for 6 key drugs, plus phase 3 (August 2024 to March 2026) regional consumption patterns and detections of 18 additional drugs.
Science & Policy
STAT+: Lobbyists and trade groups fight to shape how states regulate medical AI
Lobbying groups for doctors and hospitals and trade groups are working behind the scenes on how to regulate AI in medicine.
Science & Policy
Opinion: How states can resist the potential Trump vaccine shortages
“States can serve as a last line of defense against the Trump administration’s anti-vaccine policy,” writes Joel Dodge.
Science & Policy
Opinion: We think a baby’s gut microbiome could be key to lifelong brain health
“We need more rigorous, large-scale research into the gut-brain axis across the life course,” write Holly Baines and George Vradenburg.
Market & Brands
Scientists reveal why some workout recovery tricks can backfire
Ice baths, massages, compression garments, and recovery supplements promise faster muscle recovery, but research suggests their benefits are often overstated, and some techniques may even undermine long-term gains. Scientists say the most effective recovery methods are far sim...
Science & Policy
Cornell scientists identify rare human genetic disorder in two unusually long-legged cats
Two unusually long-legged cats have helped scientists uncover the first genetically confirmed cases of Marfan syndrome in domestic felines. Researchers at Cornell University discovered that the brothers carried two altered copies of a gene linked to the rare connective tissue ...
Science & Policy
The secret to easier exercise as an adult may start in childhood
Exercise during childhood could have a surprising lifelong benefit, potentially making physical activity less exhausting in adulthood. In a study involving guinea fowl, researchers discovered that birds accustomed to carrying weights while growing up could carry those weights ...
Science & Policy
Scientists may have overlooked a hidden Alzheimer's culprit for decades
For decades, scientists have focused on amyloid beta as a major culprit behind Alzheimer’s disease, spending billions of dollars developing treatments that have often delivered disappointing results. Now, researchers at UC Santa Cruz are drawing attention to a largely overlook...
Science & Policy
Podcast: Be skeptical of health skeptics: When debunking goes too far
Debunking misinformation is a big business. For every health "influencer" selling a supplement on Instagram, there's probably a doppelganger with a Ph.D. making a lot of money arguing against supplementation. That's not inherently wrong—unscientific nonsense should be confront...
Regulation & Policy
Scientists discover how harmful “zombie cells” hide from the immune system
Scientists have discovered a protein that may help harmful aging cells hide from the immune system, allowing them to accumulate and fuel age-related health problems. Blocking the protein in mice reduced these cells and inflammation while improving blood sugar regulation and st...
Regulation & Policy
Advisory Committee; Cellular, Tissue, and Gene Therapies Advisory Committee; Renewal
The Food and Drug Administration (FDA) is announcing the renewal of the Cellular, Tissue, and Gene Therapies Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Cellular, Ti...